Page last updated: 2024-08-23

paclitaxel and Kaposi Sarcoma

paclitaxel has been researched along with Kaposi Sarcoma in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	18 (24.66)	18.2507
2000's	23 (31.51)	29.6817
2010's	22 (30.14)	24.3611
2020's	10 (13.70)	2.80

Authors

Authors	Studies
Bassett, IV; Busakhala, N; Byakwaga, H; Freedberg, KA; Freeman, EE; Hajny Fernandez, ME; Hyle, EP; Kiprono, S; Laker-Oketta, M; Martin, JN; Maurer, T; McCann, NC; Pei, PP; Reddy, KP; Semeere, A	1
Dasanu, CA; Goff, CB	1
Ahmed, MA; Aydiner, A; Doğan, İ; Ferhatoğlu, F; Karaman, S; Khanmammadov, N; Paksoy, N	1
Borok, MZ; Burger, H; Busakhala, NW; Campbell, TB; Caruso, SR; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kosgei, J; Krown, SE; MacPhail, P; Matining, RM; Mngqibisa, R; Moser, CB; Mwelase, N; Nokta, M; Nyirenda, M; Okuku, FM; Oliver, VO; Samaneka, W	1
Bacha, JM; Campbell, LR; El-Mallawany, NK; Mehta, PS; Slone, JS; Wilkinson, JP	1
Acarlı, K; Ateş, BT; Gökçe, S; Kırımlıoğlu, H; Ocak, S; Şen, HS; Yılmazbaş, P	1
Abderrahim, E; Bacha, M; Ben Abdallah, T; Ben Hamida, F; Chargui, S; Hajji, M; Harzallah, A; Hedri, H; Ounissi, M	1
Bilgehan Sahin, A; Cubukcu, E; Deligonul, A; Evrensel, T; Ocak, B; Orhan, B; Oyucu Orhan, S	1
Anderson, MA; Chadban, S; Ferguson, PM; Gracey, DM; Grimison, P; Strach, MC; Wyburn, K; Ying, T	1
Fukai, K; Kamo, R; Nishida, M; Tsuruta, D	1
Caposiena Caro, RD; Coppola, A; Didona, D	1
Awazawa, R; Fukai, K; Kamo, R; Kusutani, N; Omura, R; Osawa, M; Ozawa, T; Tsuruta, D	1
Collins, N; Elisofon, SA; Fawaz, R; Lee, CK; Ocwieja, KE; Sharma, TS; Shulman, DS; Vakili, K; Vargas, SO	1
Kiyohara, T; Makimura, K; Miyamoto, M; Nagano, N; Nakamaru, S; Shijimaya, T; Tanimura, H	1
Asche, C; Biskupiak, J; Goodman, M; Raimundo, K; Silverstein, S	1
Aghazadeh, N; Aryanian, Z; Azizpour, A; Balighi, K; Chams-Davatchi, C; Daneshpazhooh, M; Goodarzi, A; Hejazi, P; Rahbar, Z	1
Forbes, RC; Lindsey, DE; Mansfield, SA; Papadimos, TJ; Stawicki, SP	1
Agrawal, AK; Mehta, PS; Reddy-Holdcraft, S	1
Miller, A; Natarajan, P	1
Dedicoat, M; Freeman, EE; Gbabe, OF; Okwundu, CI	1
Bower, M; Robey, RC	1
Boetticher, NC; Strickler, JG; Toma, AA; Verma, R	1
Pathak, K; Sharma, M; Sharma, V	1
Avril, MF; Denis, D; Dupin, N; Jafari, A; Kramkimel, N; Régnier-Rosencher, E	1
Afsar, CU; Duman, BB; Ercolak, V; Gunaldi, M; Sahin, B	1
Mears, KA; Weinstein, JE	1
Colucci, G; Galetta, D; Silvestris, N	1
Agbalika, F; Bouché, C; Kerob, D; Lafaurie, M; Lebbé, C; Lévy, A; Nassar, D; Schartz, NE	1
Anak, S; Aydoğan, A; Celtik, C; Durmaz, O; Gökçe, S; Güllüoğlu, M; Oztürk, G; Sökücü, S; Türkoğlu, S; Unüvar, A; Yılmaz, G	1
Aboulafia, DM; Ambinder, RF; Cianfrocca, M; Dezube, BJ; Krown, SE; Lee, JY; Lee, S; Sparano, JA; Tulpule, A; Von Roenn, J	1
Cianfrocca, M; Dezube, BJ; Krown, SE; Lee, S; Rudek, MA; Sparano, JA; Von Roenn, J	1
Ajisawa, A; Hosoda, T; Imamura, A; Kato, H; Sasaki, S; Suganuma, A; Yanagisawa, N	1
Fukao, T; Funato, M; Hirose, Y; Hori, T; Kanda, K; Kaneko, H; Kondo, N; Mizuta, K; Ozeki, M; Sasai, H; Terazawa, D	1
Espina, BM; Friedman-Kien, A; Garces, C; Gill, PS; Groopman, J; Harrington, W; Mantelle, L; Mettinger, K; Saville, MW; Scadden, DT; Tulpule, A	1
Aversa, SM; Cattelan, AM; Trevenzoli, M	1
Braverman, AS; Distant, D; Hong, J; Markell, M; Patel, N; Salifu, M; Sumrani, N	1
Ishikawa, T; Kobayashi, M; Mizutani, C; Shindo, K; Takaori-Kondo, A; Uchiyama, T	1
Bower, M; Gazzard, BG; Gotch, F; Hewitt, P; Mandalia, S; Nelson, M; Patterson, S; Portsmouth, S; Powles, T; Stebbing, J; Thirlwell, C; Wildfire, A	1
Dezube, BJ; Pantanowitz, L; Pinkus, GS; Tahan, SR	1
Aboulafia, DM; Bundow, D	1
Campbell, TB; Connick, E; Kane, MA; Ryder, J; White, IE	1
Bower, M; Dhillon, T; Stebbing, J	1
Beijnen, JH; Huitema, AD; Kappelhoff, BS; Mairuhu, AT; Schellens, JH	1
Bachelez, H; Dandurand, M; Descamps, V; Fardet, L; Kerob, D; Lebbe, C; Meunier, L; Morel, P; Stoebner, PE	1
Oka, S; Onda, J	1
Fonseca, BA; Machado, MW; Santana, Rde C; Schwartsmann, G; Sprinz, E; Vanni, T	1
Adim, SB; Ali, R; Baskan, EB; Kiyici, M; Tunali, S	1
Kato, N; Osawa, R; Yamane, N; Yanagi, T	1
Bellinvia, M; Boneschi, V; Brambilla, L; Ferrucci, S; Miedico, A; Romanelli, A; Tedeschi, L; Vinci, M	1
Broder, S; Feigal, E; Feuerstein, I; Humphrey, RW; Lietzau, J; Odom, J; Pluda, JM; Saville, MW; Steinberg, SM; Wilson, WH	1
Arbuck, SG	1
Rowinsky, EK	1
Broder, S; Fajardo, MT; Feigal, E; Feuerstein, I; Figg, WD; Humphrey, RW; Lietzau, J; Lush, R; Odom, J; Pluda, JM; Saville, MW; Steinberg, SM; Tuck, D; Welles, L; Wilson, WH; Wyvill, KM; Yarchoan, R	1
Scadden, DT; Wu, CJ	1
Howard, W; Scadden, DT; Schwartz, JD	1
Beijnen, JH; Hoetelmans, RM; Inghels, M; Meenhorst, PL; Mulder, JW; Nannan Panday, VR; van Heeswijk, RP	1
Yarchoan, R	1
Bresnahan, J; Brown, MA; Cabriales, S; Espina, BM; Gill, PS; Gustafson, NF; Ilaw, M; Louie, S; Orcutt, C; Scadden, DT; Tulpule, A; Winograd, B	1
di Gennaro, G; Juzbasic, S; Nasti, G; Tirelli, U; Vaccher, E	1
Menges, M; Pees, HW	1
Barillari, G; Carlei, D; Cereseto, A; Ciccolella, C; Ensoli, B; Monini, P; Palladino, C; Sgadari, C; Stürzl, M; Toschi, E; Yarchoan, R	1
Dezube, BJ	1
Meunier, L; Meynadier, J; Nocera, T; Stoebner, PE	1
Torres, G	1
Mascolini, M	1
Bartnof, HS	1
Levine, AM; Tulpule, A	1
Baccarini, S; Bacigalupo, I; Barillari, G; Bugarini, R; Bussolino, F; Cafaro, A; Carlei, D; Ensoli, B; Falchi, M; Leone, P; Malavasi, L; Monini, P; Palladino, C; Rezza, G; Sgadari, C; Toschi, E; Valdembri, D	1
Celik, I; Engin, H	1

Reviews

16 review(s) available for paclitaxel and Kaposi Sarcoma

Article	Year
Changing therapeutic landscape in advanced Kaposi sarcoma: Current state and future directions. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:4 Topics: Antineoplastic Agents; Doxorubicin; Humans; Neoplasm Recurrence, Local; Paclitaxel; Sarcoma, Kaposi	2023
Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries. International journal of STD & AIDS, 2020, Volume: 31, Issue:8 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Bleomycin; Doxorubicin; Drug Therapy, Combination; Female; HIV Infections; Humans; Paclitaxel; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Neoplastic; Sarcoma, Kaposi; Treatment Outcome; Vincristine	2020
Pemphigus vulgaris-associated Kaposi's sarcoma: response to paclitaxel and review of the literature. Journal of the European Academy of Dermatology and Venereology : JEADV, 2014, Volume: 28, Issue:8 Topics: Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Pemphigus; Sarcoma, Kaposi	2014
Acute upper gastrointestinal bleeding secondary to Kaposi sarcoma as initial presentation of HIV infection. Journal of gastrointestinal and liver diseases : JGLD, 2013, Volume: 22, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Biomarkers, Tumor; CD4 Lymphocyte Count; Endoscopy, Digestive System; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; HIV Infections; Humans; Immunoglobulins, Intravenous; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Paclitaxel; Positron-Emission Tomography; Purpura, Thrombocytopenic, Idiopathic; Sarcoma, Kaposi; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2013
Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. The Cochrane database of systematic reviews, 2014, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Disease Progression; Doxorubicin; Drug Therapy, Combination; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Observational Studies as Topic; Paclitaxel; Polyethylene Glycols; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Vincristine	2014
Facing up to the ongoing challenge of Kaposi's sarcoma. Current opinion in infectious diseases, 2015, Volume: 28, Issue:1 Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Developed Countries; Developing Countries; Doxorubicin; Drug Therapy, Combination; Evidence-Based Medicine; Health Care Rationing; Herpesvirus 8, Human; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Incidence; Paclitaxel; Polyethylene Glycols; Sarcoma, Kaposi	2015
Kaposi's sarcoma after long-acting steroids: time until remission and drug washout. Dermatology (Basel, Switzerland), 2010, Volume: 220, Issue:2 Topics: Anti-Inflammatory Agents; Bleomycin; Blood Glucose; CD4 Lymphocyte Count; Humans; Immunoglobulin G; Immunosuppression Therapy; Insulin; Interferon-alpha; Male; Middle Aged; Opportunistic Infections; Paclitaxel; Sarcoma, Kaposi; Skin Ulcer; Triamcinolone Acetonide	2010
Paclitaxel-based chemotherapy for aggressive kaposiform hemangioendothelioma of the temporomastoid region: Case report and review of the literature. Head & neck, 2013, Volume: 35, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Child; Head and Neck Neoplasms; Hemangioendothelioma; Humans; Kasabach-Merritt Syndrome; Lung Neoplasms; Male; Paclitaxel; Sarcoma, Kaposi	2013
Recent advances in the treatment of AIDS-related Kaposi's sarcoma. American journal of clinical dermatology, 2002, Volume: 3, Issue:7 Topics: AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Humans; Interferons; Paclitaxel; Sarcoma, Kaposi; Tretinoin	2002
Paclitaxel for AIDS-associated Kaposi's sarcoma. Expert review of anticancer therapy, 2005, Volume: 5, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Algorithms; Anti-Retroviral Agents; Antineoplastic Agents, Phytogenic; Herpesviridae Infections; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Sarcoma, Kaposi	2005
[Treatment of KSHV infection]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 3 Topics: Acquired Immunodeficiency Syndrome; Angiogenesis Inhibitors; Anthracyclines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Herpesvirus 8, Human; Humans; Interferon alpha-2; Interferon-alpha; Paclitaxel; Radiotherapy; Recombinant Proteins; Sarcoma, Kaposi; Thalidomide; Vinblastine	2006
Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives. Cancer treatment reviews, 2006, Volume: 32, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Antiviral Agents; Clinical Trials as Topic; Humans; Interferons; Liposomes; Male; Paclitaxel; Sarcoma, Kaposi	2006
Paclitaxel pharmacology and other tumor types. Seminars in oncology, 1997, Volume: 24, Issue:6 Suppl 19 Topics: Alkylating Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Endometrial Neoplasms; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphoma; Male; Neoplasms; Neoplasms, Unknown Primary; Paclitaxel; Platinum Compounds; Sarcoma, Kaposi; Stomach Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine	1997
Therapy for Kaposi's sarcoma: recent advances and experimental approaches. Journal of acquired immune deficiency syndromes (1999), 1999, Aug-01, Volume: 21 Suppl 1 Topics: Administration, Oral; Alitretinoin; Anthracyclines; Antineoplastic Agents; Cyclohexanes; Humans; Immunosuppressive Agents; Liposomes; Neoplasms; O-(Chloroacetylcarbamoyl)fumagillol; Paclitaxel; Sarcoma, Kaposi; Sesquiterpenes; Thalidomide; Tretinoin	1999
New therapies for the treatment of AIDS-related Kaposi sarcoma. Current opinion in oncology, 2000, Volume: 12, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Humans; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Paclitaxel; Sarcoma, Kaposi	2000
Clinical aspects and management of AIDS-related Kaposi's sarcoma. European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:10 Topics: Angiogenesis Inhibitors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Dipeptides; Humans; Infusions, Intravenous; Paclitaxel; Retinoids; Sarcoma, Kaposi; Thalidomide	2001

Trials

9 trial(s) available for paclitaxel and Kaposi Sarcoma

Article	Year
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial. Lancet (London, England), 2020, 04-11, Volume: 395, Issue:10231 Topics: Adult; Africa; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Developing Countries; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Paclitaxel; Progression-Free Survival; Sarcoma, Kaposi; Vincristine	2020
Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer, 2010, Aug-15, Volume: 116, Issue:16 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Disease-Free Survival; Doxorubicin; Early Termination of Clinical Trials; Female; HIV Infections; Humans; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Quality of Life; Sarcoma, Kaposi	2010
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Area Under Curve; Disease-Free Survival; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Paclitaxel; Pilot Projects; Sarcoma, Kaposi	2011
Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer, 2002, Jul-01, Volume: 95, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Female; Humans; Male; Middle Aged; Paclitaxel; Protease Inhibitors; Quality of Life; Sarcoma, Kaposi; Survival Rate	2002
Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Anthracyclines; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Biomarkers, Tumor; Disease Progression; Female; Fibroblast Growth Factor 2; Humans; Interleukin-6; Male; Middle Aged; Neovascularization, Pathologic; Paclitaxel; Sarcoma, Kaposi; Skin Neoplasms; Time Factors; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2003
Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection. Cancer, 2006, Apr-15, Volume: 106, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Docetaxel; Female; HIV Seronegativity; Humans; Male; Middle Aged; Paclitaxel; Sarcoma, Kaposi; Skin Neoplasms; Taxoids	2006
Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet (London, England), 1995, Jul-01, Volume: 346, Issue:8966 Topics: Acquired Immunodeficiency Syndrome; Adult; Cimetidine; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Sarcoma, Kaposi	1995
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Paclitaxel; Probability; Recombinant Proteins; Remission Induction; Sarcoma, Kaposi; Survival Analysis	1998
Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Edema; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Treatment Outcome	1999

Other Studies

48 other study(ies) available for paclitaxel and Kaposi Sarcoma

Article	Year
Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis. The Lancet. Global health, 2022, Volume: 10, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Bleomycin; Cost-Benefit Analysis; Etoposide; HIV Infections; Humans; Kenya; Paclitaxel; Sarcoma, Kaposi; Vincristine	2022
Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study. Medicine, 2023, Feb-03, Volume: 102, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Sectional Studies; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms	2023
Successful treatment of pediatric post-liver transplant Kaposi`s sarcoma with paclitaxel. The Turkish journal of pediatrics, 2020, Volume: 62, Issue:5 Topics: Adult; Child; Humans; Immunosuppression Therapy; Liver Transplantation; Paclitaxel; Sarcoma, Kaposi; Transplant Recipients	2020
[Successful treatment with paclitaxel of a visceral relapse of post-transplant Kaposi's sarcoma]. Nephrologie & therapeutique, 2021, Volume: 17, Issue:2 Topics: Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasm Recurrence, Local; Paclitaxel; Sarcoma, Kaposi	2021
Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data. Bosnian journal of basic medical sciences, 2021, Dec-01, Volume: 21, Issue:6 Topics: Adult; Aged; Aged, 80 and over; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Doxorubicin; Female; Humans; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Retrospective Studies; Sarcoma, Kaposi; Survival Rate; Turkey	2021
Transplant-associated penile Kaposi sarcoma managed with single agent paclitaxel chemotherapy: a case report. BMC urology, 2021, Jun-07, Volume: 21, Issue:1 Topics: Aged; Antineoplastic Agents, Phytogenic; Humans; Kidney Transplantation; Male; Paclitaxel; Penile Neoplasms; Postoperative Complications; Sarcoma, Kaposi	2021
Case of chronic venous insufficiency-associated Kaposi's sarcoma in a Japanese patient. The Journal of dermatology, 2017, Volume: 44, Issue:12 Topics: Aged; Antineoplastic Agents, Phytogenic; Biopsy; Chronic Disease; Diagnosis, Differential; Humans; Immunohistochemistry; Japan; Lower Extremity; Male; Paclitaxel; Sarcoma, Kaposi; Venous Insufficiency	2017
Kaposi's sarcoma lung metastastis in transplanted patient treatment response with paclitaxel and everolimus. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2020, Volume: 155, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Everolimus; Female; Humans; Kidney Transplantation; Lung Neoplasms; Paclitaxel; Sarcoma, Kaposi; Treatment Outcome	2020
Effectiveness of weekly paclitaxel for edema and pain in classic Kaposi sarcoma with widespread eruption in the lower legs. The Journal of dermatology, 2019, Volume: 46, Issue:5 Topics: Aged; Cancer Pain; Drug Administration Schedule; Edema; Female; Foot; Herpesvirus 8, Human; Humans; Paclitaxel; Sarcoma, Kaposi; Skin; Skin Neoplasms; Treatment Outcome	2019
Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8. Pediatric transplantation, 2019, Volume: 23, Issue:3 Topics: Biliary Atresia; Biopsy, Needle; Disease Progression; Female; Ganciclovir; Herpesvirus 8, Human; Humans; Immunosuppression Therapy; Infant; Liver; Liver Transplantation; Magnetic Resonance Imaging; Male; Paclitaxel; Postoperative Complications; Sarcoma, Kaposi; Tissue Donors	2019
Radiation-associated angiosarcoma with histological features reminiscent of Kaposi's sarcoma successfully treated by radiotherapy with paclitaxel. The Journal of dermatology, 2019, Volume: 46, Issue:10 Topics: Aged, 80 and over; Breast; Breast Neoplasms; Chemoradiotherapy; Diagnosis, Differential; Dose Fractionation, Radiation; Female; Hemangiosarcoma; Humans; Mastectomy, Segmental; Neoplasms, Radiation-Induced; Paclitaxel; Radiotherapy, Adjuvant; Sarcoma, Kaposi; Skin; Treatment Outcome	2019
Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi's sarcoma. Journal of medical economics, 2013, Volume: 16, Issue:5 Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Decision Trees; Doxorubicin; Humans; Liposomes; Paclitaxel; Sarcoma, Kaposi	2013
Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposi's sarcoma. AIDS (London, England), 2014, Mar-13, Volume: 28, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Child; HIV Infections; Humans; Male; Paclitaxel; Radiography, Thoracic; Recurrence; Sarcoma, Kaposi; Treatment Outcome	2014
A case of relapsed visceral Kaposi's sarcoma with bilateral chylothoraces successfully treated with paclitaxel. International journal of STD & AIDS, 2015, Volume: 26, Issue:8 Topics: Adult; Antineoplastic Agents, Phytogenic; Chylothorax; HIV Infections; Humans; Male; Paclitaxel; Recurrence; Sarcoma, Kaposi; Treatment Outcome	2015
Education and imaging. Gastrointestinal: Gastric involvement in disseminated lymphadenopathic Kaposi sarcoma. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Doxorubicin; Endoscopy, Digestive System; Etoposide; Humans; Interferons; Male; Paclitaxel; Palliative Care; Sarcoma, Kaposi; Stomach Neoplasms	2015
Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma. Artificial cells, nanomedicine, and biotechnology, 2016, Volume: 44, Issue:7 Topics: Animals; Drug Carriers; Humans; Nanostructures; Paclitaxel; Rats; Sarcoma, Kaposi; Skin Neoplasms	2016
First-line treatment with paclitaxel for non-HIV-related Kaposi sarcoma: experience in 10 cases. The British journal of dermatology, 2016, Volume: 174, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Off-Label Use; Paclitaxel; Sarcoma, Kaposi; Treatment Outcome	2016
Efficacy of paclitaxel in the treatment of Kaposi sarcoma. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:21 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Sarcoma, Kaposi; Treatment Outcome	2015
Periocular Kaposi Sarcoma as the Initial Presentation of Human Immunodeficiency Virus. JAMA ophthalmology, 2016, 10-13, Volume: 134, Issue:10 Topics: Adult; Anti-Retroviral Agents; Antineoplastic Agents, Phytogenic; CD4 Lymphocyte Count; Drug Therapy, Combination; Eyelid Diseases; HIV Infections; HIV Seropositivity; Humans; Male; Paclitaxel; Sarcoma, Kaposi	2016
Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma. Anticancer research, 2009, Volume: 29, Issue:2 Topics: Aged, 80 and over; Anthracyclines; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Male; Paclitaxel; Sarcoma, Kaposi	2009
Human herpes virus type 8-associated Kaposi sarcoma in a pediatric liver transplant recipient. Pediatric transplantation, 2011, Volume: 15, Issue:5 Topics: Antineoplastic Agents; Female; Herpesvirus 8, Human; Humans; Immunosuppressive Agents; Infant; Liver Failure; Liver Transplantation; Lymphoproliferative Disorders; Paclitaxel; Prognosis; Sarcoma, Kaposi; Sirolimus; Treatment Outcome	2011
[Refractory AIDS-associated Kaposi's sarcoma treated successfully with paclitaxel: a case report]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2012, Volume: 86, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Doxorubicin; Humans; Male; Middle Aged; Paclitaxel; Polyethylene Glycols; Sarcoma, Kaposi	2012
Successful treatment of post-renal transplant Kaposi's sarcoma with paclitaxel. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2002, Volume: 2, Issue:9 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Humans; Kidney Transplantation; Paclitaxel; Sarcoma, Kaposi	2002
Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma. Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Humans; Lung Neoplasms; Male; Paclitaxel; Sarcoma, Kaposi; Treatment Outcome	2002
Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. Journal of cutaneous pathology, 2004, Volume: 31, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Dermatitis; Diagnosis, Differential; Humans; Immunoenzyme Techniques; Immunophenotyping; Male; Middle Aged; Paclitaxel; Pigmentation Disorders; Purpura; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Tetracyclines	2004
Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma. American journal of clinical oncology, 2004, Volume: 27, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Drug Interactions; Humans; Male; Middle Aged; Paclitaxel; Sarcoma, Kaposi	2004
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Dec-15, Volume: 39, Issue:12 Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; DNA, Viral; Female; Herpesvirus 8, Human; HIV Infections; HIV-1; Humans; Immune System Diseases; Inflammation; Male; Paclitaxel; Sarcoma, Kaposi; Syndrome; Viral Load	2004
No pharmacokinetic drug-drug interaction between nevirapine and paclitaxel. Anti-cancer drugs, 2005, Volume: 16, Issue:6 Topics: Adult; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; HIV Infections; HIV-1; Humans; Lamivudine; Leg; Male; Nevirapine; Paclitaxel; Palatal Neoplasms; Sarcoma, Kaposi; Skin Neoplasms; Stavudine	2005
Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy. International journal of dermatology, 2006, Volume: 45, Issue:12 Topics: Aged; Antineoplastic Agents, Phytogenic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Sarcoma, Kaposi; Skin Neoplasms; Treatment Outcome	2006
Clearance of recurrent, classical Kaposi's sarcoma using multiple paclitaxel treatments. Acta dermato-venereologica, 2007, Volume: 87, Issue:5 Topics: Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms	2007
Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases. The British journal of dermatology, 2008, Volume: 158, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Microtubules; Middle Aged; Paclitaxel; Sarcoma, Kaposi; Treatment Outcome; Vascular Neoplasms	2008
Paclitaxel: current developmental approaches of the National Cancer Institute. Seminars in oncology, 1995, Volume: 22, Issue:6 Suppl 15 Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Administration Schedule; Endometrial Neoplasms; Esophageal Neoplasms; Female; Germinoma; Head and Neck Neoplasms; Humans; Lung Neoplasms; National Institutes of Health (U.S.); Ovarian Neoplasms; Paclitaxel; Sarcoma, Kaposi; United States; Urinary Bladder Neoplasms	1995
Posttransplant Kaposi's sarcoma treated with paclitaxel. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Heart Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Paclitaxel; Sarcoma, Kaposi; Skin Neoplasms	1998
Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma. AIDS (London, England), 1999, Feb-04, Volume: 13, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Delavirdine; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Male; Paclitaxel; Reverse Transcriptase Inhibitors; Saquinavir; Sarcoma, Kaposi	1999
Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study. Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents, Phytogenic; Drug Interactions; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Paclitaxel; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi	1999
European Committee signs off on Paxene for Kaposi's sarcoma treatment. The oncologist, 1999, Volume: 4, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Drug Approval; Europe; Humans; Paclitaxel; Sarcoma, Kaposi	1999
HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy. Journal of acquired immune deficiency syndromes (1999), 1999, Dec-01, Volume: 22, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Humans; Male; Paclitaxel; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Vinblastine; Vinorelbine	1999
Kaposi's sarcoma of the pancreas mimicking pancreatic cancer in an HIV-infected patient. Clinical diagnosis by detection of HHV 8 in bile and complete remission following antiviral and cytostatic therapy with paclitaxel. International journal of pancreatology : official journal of the International Association of Pancreatology, 1999, Volume: 26, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antiviral Agents; Bile; Cholangiopancreatography, Endoscopic Retrograde; Diagnosis, Differential; Herpesvirus 8, Human; HIV Infections; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Radiography, Abdominal; Remission Induction; Sarcoma, Kaposi; Tomography, X-Ray Computed	1999
Mechanism of paclitaxel activity in Kaposi's sarcoma. Journal of immunology (Baltimore, Md. : 1950), 2000, Jul-01, Volume: 165, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Down-Regulation; Growth Inhibitors; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Paclitaxel; Proto-Oncogene Mas; Proto-Oncogene Proteins c-bcl-2; Sarcoma, Experimental; Sarcoma, Kaposi; Tumor Cells, Cultured	2000
Efficacy of docetaxel in disseminated classical Kaposi's sarcoma. The British journal of dermatology, 2000, Volume: 143, Issue:6 Topics: Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Humans; Male; Paclitaxel; Sarcoma, Kaposi; Taxoids	2000
Broad activist support for paclitaxel as second-line treatment for Kaposi's sarcoma. AIDS patient care and STDs, 1997, Volume: 11, Issue:5 Topics: Antineoplastic Agents, Phytogenic; HIV Infections; Humans; Paclitaxel; Sarcoma, Kaposi	1997
Second National Retrovirus conference: a further report. GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:3 Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cause of Death; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Ganciclovir; Humans; Male; Organophosphonates; Organophosphorus Compounds; Paclitaxel; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Tuberculosis	1995
Oncologists scout new directions for KS and lymphoma therapies. Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chorionic Gonadotropin; Female; Humans; Isotretinoin; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Mitoguazone; Paclitaxel; Palliative Care; Photochemotherapy; Recurrence; Sarcoma, Kaposi; Uterine Cervical Neoplasms	1995
Low-dose paclitaxel effective in advanced KS. BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1997 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Male; Paclitaxel; Sarcoma, Kaposi	1997
Paclitaxel for treating KS. Project Inform perspective, 1997, Issue:23 Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Carriers; Humans; Liposomes; Paclitaxel; Sarcoma, Kaposi	1997
Taxol may prolong remission of KS. TreatmentUpdate, 1999, Aug-01, Volume: 11, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Disease-Free Survival; Drug Interactions; HIV Infections; Humans; Paclitaxel; Protease Inhibitors; Sarcoma, Kaposi; Treatment Outcome	1999
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nature medicine, 2002, Volume: 8, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Endothelial Growth Factors; Endothelium, Vascular; Extraembryonic Membranes; Female; Fibroblast Growth Factor 2; HIV Protease Inhibitors; Humans; Indinavir; Lymphokines; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Saquinavir; Sarcoma, Kaposi; Skin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel. Clinical oncology (Royal College of Radiologists (Great Britain)), 2002, Volume: 14, Issue:2 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Paclitaxel; Sarcoma, Kaposi; Skin Neoplasms	2002